ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 593 filers reported holding ISHARES TR in Q3 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $11,000 | -89.1% | 70 | -89.6% | 0.01% | -86.0% |
Q1 2021 | $101,000 | 0.0% | 670 | 0.0% | 0.04% | -8.5% |
Q4 2020 | $101,000 | -84.7% | 670 | -86.3% | 0.05% | -86.2% |
Q3 2020 | $662,000 | -2.8% | 4,890 | -1.8% | 0.34% | -6.1% |
Q2 2020 | $681,000 | +24.7% | 4,980 | -1.7% | 0.36% | +4.6% |
Q1 2020 | $546,000 | -6.5% | 5,065 | +4.5% | 0.35% | +32.1% |
Q4 2019 | $584,000 | +25.1% | 4,845 | +3.3% | 0.26% | +22.4% |
Q3 2019 | $467,000 | -3.5% | 4,690 | +5.6% | 0.21% | -3.6% |
Q2 2019 | $484,000 | +129.4% | 4,440 | +134.9% | 0.22% | +144.0% |
Q1 2019 | $211,000 | +8.8% | 1,890 | -6.0% | 0.09% | 0.0% |
Q4 2018 | $194,000 | -20.8% | 2,010 | 0.0% | 0.09% | -1.1% |
Q3 2018 | $245,000 | -3.5% | 2,010 | -13.0% | 0.09% | -12.4% |
Q2 2018 | $254,000 | -80.6% | 2,310 | -81.2% | 0.10% | -72.1% |
Q1 2018 | $1,311,000 | -0.4% | 12,283 | -0.4% | 0.38% | -2.1% |
Q4 2017 | $1,316,000 | -19.6% | 12,328 | +151.4% | 0.38% | -29.9% |
Q3 2017 | $1,636,000 | +8.6% | 4,903 | +0.9% | 0.55% | +2.4% |
Q2 2017 | $1,506,000 | +10.4% | 4,858 | +4.5% | 0.54% | -28.5% |
Q1 2017 | $1,364,000 | -0.3% | 4,650 | -9.8% | 0.75% | -5.2% |
Q4 2016 | $1,368,000 | -9.9% | 5,155 | -1.7% | 0.79% | -11.9% |
Q3 2016 | $1,518,000 | +1.5% | 5,245 | -9.7% | 0.90% | -2.4% |
Q2 2016 | $1,495,000 | +5.6% | 5,810 | +7.0% | 0.92% | +8.2% |
Q1 2016 | $1,416,000 | -17.2% | 5,430 | +7.4% | 0.85% | -20.8% |
Q4 2015 | $1,710,000 | +20.4% | 5,055 | +7.9% | 1.07% | +7.3% |
Q3 2015 | $1,420,000 | -19.0% | 4,683 | -1.5% | 1.00% | -4.9% |
Q2 2015 | $1,754,000 | +3.4% | 4,753 | -3.7% | 1.05% | +4.0% |
Q1 2015 | $1,696,000 | -5.9% | 4,938 | -16.9% | 1.01% | -3.2% |
Q4 2014 | $1,803,000 | +10.7% | 5,943 | -0.2% | 1.04% | +27.9% |
Q3 2014 | $1,629,000 | +4.0% | 5,953 | -2.3% | 0.82% | +8.7% |
Q2 2014 | $1,566,000 | +13.6% | 6,093 | +4.5% | 0.75% | +69.9% |
Q1 2014 | $1,379,000 | +7.7% | 5,833 | +3.4% | 0.44% | -0.2% |
Q4 2013 | $1,281,000 | +13.4% | 5,643 | +4.6% | 0.44% | +4.0% |
Q3 2013 | $1,130,000 | +22.8% | 5,393 | +1.9% | 0.43% | +28.7% |
Q2 2013 | $920,000 | – | 5,293 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |